DexCom Inc. (DXCM) shares fell 6.4% to $80.26 on October 21, 2026. Net insider selling totaled $11.8 million over the preceding 12 months.

Key Takeaways

  • Insiders bought $1.0 million of shares and sold $12.8 million over 12 months.

Table of Contents

DexCom shares retreat while retaining longer-term gains

The daily fall contrasted with gains over longer periods: DexCom remained up 20.9% year to date and 15.1% over the preceding year. Its reported 52-week trading range was $54.11 to $92.59.

Price-to-earnings ratios

The stock’s trailing price-to-earnings ratio was 31.7 times, compared with a five-year median of 84.4 times. Its forward P/E was 25.6 times.

Insider transactions

Insider purchases totaled $1.0 million against $12.8 million in sales during the past 12 months, leaving net sales of $11.8 million.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.